Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q4 2021 Torrent Pharmaceuticals Ltd Earnings Call Transcript

May 18, 2021 / 12:00PM GMT
Release Date Price: ₹1361.85 (-1.52%)
Operator

Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q4 FY '21 Earnings Conference Call. We have with us today Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Executive Director and Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India business. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - CFO

Yes. Thank you. Good evening, everyone, and welcome to quarter 4 FY '21 earnings call. We hope you and your families are keeping safe and healthy.

Quarter 4 continued to witness mixed wells of COVID recovery across the market. In the midst of the second wave of pandemic in certain geographies we operate, and particularly in India, we continue to give highest priority to the health and safety of all our employees and their families while ensuring continuity of supplies to fulfill patient needs.

In

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot